Bibliografia UJ CM

1/9
Nina D. Wagner-Johnston, Stephen J. Schuster, Sven deVos, Gilles Salles, Wojciech Jurczak, Christopher R. Flowers, Andreas Viardot, Ian W. Flinn, Peter Martin, Guan Xing, Nishanthan Rajakumaraswamy, Ajay K. Gopal.
Outcomes of patients with up to 6 years of follow-up from a phase 2 study of idelalisib for relapsed indolent lymphomas.
Leukemia & Lymphoma
2021 : Vol. 62, nr 5, s. 1077-1087, bibliogr., abstr.
Autor korespondencyjny: Nina D. Wagner-Johnston
p-ISSN: 1042-8194
AZ
ORG
AIF
IF: 2.996
Adres url:
Streszczenie w PubMed:
DOI:
2/9
Ajay K. Gopal, Stephen J. Schuster, Nathan H. Fowler, Judith Trotman, Georg Hess, Jing-Zhou Hou, Abdulraheem Yacoub, Michael Lill, Peter Martin, Umberto Vitolo, Andrew Spencer, John Radford, Wojciech Jurczak, James Morton, Dolores Caballero, Sanjay Deshpande, Gary J. Gartenberg, Shean-sheng Wang, Rajendra N. Damle, Michael Schaffer, Sriram Balasubramanian, Jessica Vermeulen, Bruce D. Cheson, Gilles Salles.
Ibrutinib as Treatment for Patients With Relapsed/Refractory Follicular Lymphoma: Results From the Open-Label, Multicenter, Phase II DAWN Study.
Journal of Clinical Oncology
2018 : Vol. 36, nr 23, s. 2405-2412
Autor korespondencyjny: Ajay K. Gopal.
p-ISSN: 0732-183X
AZ
ORG
AIF
IF: 28.245
Adres url:
Streszczenie w PubMed:
DOI:
3/9
Gilles Salles, Stephen J. Schuster, Sven de Vos, Nina D. Wagner-Johnston, Andreas Viardot, Kristie A. Blum, Christopher R. Flowers, Wojciech J. Jurczak, Ian W. Flinn, Brad S. Kahl, Peter Martin, Yeonhee Kim, Sanatan Shreay, Matthias Will, Bess Sorensen, Madlaina Breuleux, Pier Luigi Zinzani, Ajay K. Gopal.
Efficacy and safety of idelalisib in patients with relapsed, rituximab- and alkylating agent-refractory follicular lymphoma: a subgroup analysis of a phase 2 study.
Haematologica
2017 : Vol. 102, nr 4, s. e156-e159, il., bibliogr., abstr.
Open Access Creative Commons Attribution License CC-BY.
Autor korespondencyjny: Ajay K. Gopal.
Data udostępnienia w sposób otwarty: 2016-12-15
p-ISSN: 0390-6078
AZ
ORG
AIF
IF: 9.090
BB: PubMed ; Scopus ; Web of Science Core Collection
PubMed; Scopus; Web of Science Core Collection
Adres url:
Streszczenie w PubMed:
4/9
Ajay K. Gopal, Stephen J. Schuster, Nathan Fowler, Judith Trotman, Georg Hess, Jing-Zhou Hou, Abdulraheem Yacoub, Michael Lill, Peter Martin, Umberto Vitolo, Wojciech Jurczak, James Morton, Dzhelil Osmanov, Gary J. Gartenberg, Jessica Vermeulen, Sriram Balasubramanian, Shean-sheng Wang, Sanjay Deshpande, Gilles A. Salles.
Ibrutinib As Treatment for Chemoimmunotherapy-Resistant Patients with Follicular Lymphoma: First Results from the Open-Label, Multicenter, Phase 2 DAWN Study.
Blood
2016 : Vol. 128, nr 22, s. 1217
58th ASH Annual Meeting & Exposition, San Diego, California, 3-5 December 2016.
p-ISSN: 0006-4971
SZZ
SIF
Adres url:
5/9
Peter Martin, Kami Maddocks, John P. Leonard, Jia Ruan, Andre Goy, Nina Wagner-Johnston, Simon Rule, Ranjana Advani, David Iberri, Tycel Phillips, Stephen Spurgeon, Eliana Kozin, Katherine Noto, Zhengming Chen, Wojciech Jurczak, Rebecca Auer, Ewa Chmielowska, Stephan Stilgenbauer, Johannes Bloehdorn, Craig Portell, Michael E. Williams, Martin Dreyling, Paul M. Barr, Selina Chen-Kiang, Maurizio DiLiberto, Richard R. Furman, Kristie A. Blum.
Postibrutinib outcomes in patients with mantle cell lymphoma.
Blood
2016 : Vol. 127, nr 12, s. 1559-1563, il., bibliogr. 14 poz., abstr.
p-ISSN: 0006-4971
AZ
ORG
AIF
IF: 13.164
Adres url:
Streszczenie w PubMed:
6/9
Michael L. Wang, Kristie A. Blum, Peter Martin, Andre Goy, Rebecca Auer, Brad S. Kahl, Wojciech Jurczak, Ranjana H. Advani, Jorge E. Romaguera, Michael E. Williams, Jacqueline C. Barrientos, Ewa Chmielowska, John Radford, Stephan Stilgenbauer, Martin Dreyling, Wieslaw Wiktor Jedrzejczak, Peter Johnson, Stephen E. Spurgeon, Liang Zhang, Linda Baher, Mei Cheng, Dana Lee, Darrin M. Beaupre, Simon Rule.
Long-term follow-up of MCL patients treated with single-agent ibrutinib: Updated safety and efficacy results.
Blood
2015 : Vol. 126, nr 6, s. 739-745, il., bibliogr. 14 poz., abstr.
p-ISSN: 0006-4971
AZ
ORG
AIF
IF: 11.847
Adres url:
Streszczenie w PubMed:
7/9
Ajay K. Gopal, Brad S. Kahl, Sven Vos, de, Nina D. Wagner-Johnston, Stephen J. Schuster, Wojciech J. Jurczak, Ian W. Flinn, Christopher R. Flowers, Peter Martin, Andreas Viardot, Kristie A. Blum, Andre H. Goy, Andrew J. Davies, Pier Luigi Zinzani, Martin Dreyling, Dave Johnson, Langdon L. Miller, Leanne Holes, Daniel Li, Roger D. Dansey, Wayne R. Godfrey, Gilles A. Salles.
PI3KΔ inhibition by idelalisib in patients with relapsed indolent lymphoma.
New England Journal of Medicine
2014 : Vol. 370, nr 11, s. 1008-1018, il., bibliogr., abstr.
p-ISSN: 0028-4793
AZ
ORG
AIF
IF: 55.873
Adres url:
8/9
Wojciech Jurczak, Simon Rule, Peter Martin, Rebecca Auer, Brad S. Kahl, Agnieszka Giza, Bożena Jachimczak, Ranjana H. Advani, Jorge Romaguera, Michael Williams, Jacqueline Barrientos, Ewa Chmielowska, John Radford, Stephan Stilgenbauer, Jesse McGreivy, Fong Clow, Darrin M. Beaupre, Lori Kunkel, Andre Goy, Kristie A. Blum, Wiktor Jędrzejczak, Michael L. Wang.
Inhibitor kinazy Brutona u chorych z nawrotowym lub opornym na leczenie chłoniakiem z komórek płaszcza - wyniki międzynarodowego, wieloośrodkowego, badania II fazy z ibrutynibem (PCI-32765) - EHA Encore.
(Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma - Results of an International, Multicenter, Phase 2 Study of Ibrutinib (PCI-32765) - EHA Encore.)
Acta Haematologica Polonica
2013 : Vol. 44, nr 3, s. 314-318, il., bibliogr. 7 poz., abstr.
p-ISSN: 0001-5814
AP
ORG
KBN
Adres url:
DOI:
9/9
Michael L. Wang, Simon Rule, Peter Martin, Andre Goy, Rebecca Auer, Bras S. Kahl, Wojciech Jurczak, Ranjana H. Advani, Jorge E. Romaguera, Michael E. Williams, Jacqueline C. Barrientos, Ewa Chmielowska, John Radford, Stephan Stilgenbauer, Martin Dreyling, Wieslaw Wiktor Jedrzejczak, Peter Johnson, Stephen E. Spurgeon, Lei Li, Liang Zhang, Kate Newberry, Zhishuo Ou, Nancy Cheng, Bingliang Fang, Jesse McGreivy, Fong Clow, Joseph J. Buggy, Betty Y. Chang, Darrin M. Beaupre, Lori A. Kunkel, Kristie A. Blum.
Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma.
New England Journal of Medicine
2013 : Vol. 369, nr 6, s. 507-516, il., bibliogr. 29 poz., abstr.
p-ISSN: 0028-4793
AZ
ORG
AIF
IF: 54.420
Adres url:
Wyświetl ponownie stosując format:

Wyświetl/ukryj etykiety | Wyświetlenie wyników w wersji do druku | Pobranie pliku do edytora | Nowe wyszukiwanie | Biblioteka Medyczna UJ